Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000041710 | SCV000065406 | pathogenic | Rare genetic deafness | 2011-06-21 | criteria provided, single submitter | clinical testing | The Trp3985X variant in USH2A has not been reported in the literature nor previo usly identified by our laboratory. The Trp3985X variant leads to a premature sto p codon at position 3985, which is predicted to lead to a truncated or absent pr otein. In summary, this variant meets our criteria to be classified as pathogeni c. |
Counsyl | RCV000669396 | SCV000794144 | likely pathogenic | Usher syndrome type 2A; Retinitis pigmentosa 39 | 2017-09-15 | criteria provided, single submitter | clinical testing | |
Blueprint Genetics | RCV001075329 | SCV001240947 | likely pathogenic | Retinal dystrophy | 2018-02-20 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001852856 | SCV002237021 | pathogenic | not provided | 2023-12-11 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Trp3985*) in the USH2A gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in USH2A are known to be pathogenic (PMID: 10729113, 10909849, 20507924, 25649381). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with USH2A-related conditions. ClinVar contains an entry for this variant (Variation ID: 48388). For these reasons, this variant has been classified as Pathogenic. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003226175 | SCV003922467 | likely pathogenic | Usher syndrome | 2023-03-17 | criteria provided, single submitter | clinical testing | Variant summary: USH2A c.11954G>A (p.Trp3985X) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory. The variant was absent in 251330 control chromosomes (gnomAD). To our knowledge, no occurrence of c.11954G>A in individuals affected with Usher Syndrome and no experimental evidence demonstrating its impact on protein function have been reported. Three clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 and all classified the variant as pathogenic/likely pathogenic. Based on the evidence outlined above, the variant was classified as likely pathogenic. |
Genome- |
RCV003450757 | SCV004182054 | likely pathogenic | Retinitis pigmentosa 39 | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003450756 | SCV004182055 | likely pathogenic | Usher syndrome type 2A | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV003450757 | SCV005055771 | pathogenic | Retinitis pigmentosa 39 | 2023-12-01 | criteria provided, single submitter | clinical testing | |
Institute of Human Genetics, |
RCV001075329 | SCV005072526 | pathogenic | Retinal dystrophy | 2020-01-01 | no assertion criteria provided | clinical testing |